5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA)
Authors:
- 1 January 2006
- journal article
- Published by Springer Nature in American Journal of Cancer
- Vol. 5 (3) , 155-162
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Rat Tumor Response to the Vascular-Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Plasma 5-Hydroxyindoleacetic Acid Levels, and Tumor NecrosisNeoplasia, 2006
- Tumor Vascular Response to Photodynamic Therapy and the Antivascular Agent 5,6-Dimethylxanthenone-4-Acetic Acid: Implications for Combination TherapyClinical Cancer Research, 2005
- Disrupting tumour blood vesselsNature Reviews Cancer, 2005
- Tumour vascular targetingNature Reviews Cancer, 2005
- Tumor Dose Response to the Vascular Disrupting Agent, 5,6-Dimethylxanthenone-4-Acetic Acid, Using In vivo Magnetic Resonance SpectroscopyClinical Cancer Research, 2005
- Mechanisms of tumor vascular shutdown induced by 5,6‐dimethylxanthenone‐4‐acetic acid (DMXAA): Increased tumor vascular permeabilityInternational Journal of Cancer, 2005
- Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate CancerNew England Journal of Medicine, 2004
- Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)Cancer Chemotherapy and Pharmacology, 2003
- Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acidInternational Journal of Hyperthermia, 2001
- Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acidInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998